Literature DB >> 32119879

Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort.

Michael C Haffner1, Daniela C Salles2, Guofeng Gao3, Jonathan I Epstein4.   

Abstract

The prognostic significance of the Gleason grading system has been well established. However, individual Gleason patterns comprise heterogeneous morphologies which might add additional prognostic information. Recent evidence suggests that Gleason pattern 4 with cribriform growth pattern is associated with an adverse prognosis. To determine the association between cribriform pattern on biopsies and pathological findings on subsequent prostatectomies, we evaluated the presence of cribriform architecture in a prospective cohort of 367 men from 2014 to 2018 treated at a single institution. Cribriform architecture was present in 63.5% of all biopsies and was correlated with the overall extent of Gleason pattern 4. In addition, cribriform morphology on biopsy showed a statistically significant association with higher Gleason grade and increased pathological stage and nodal metastasis. In a subset analysis of cases with Grade Group 2 (Gleason score 3 + 4, n = 208), these associations did not reach statistical significance, but the presence of cribriform growth in this subgroup showed a trend toward increased upgrading to Grade Group 5 (Gleason score 9/10) (1 [0.5%] vs. 5 [2.4%], P = 0.06). This large prospective study comparing biopsy and prostatectomy finding of cribriform architecture demonstrates that cribriform pattern 4 is associated with adverse prognostic features and highlights the relevance for recognizing specific morphologies with distinct biological and clinical features.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopsy; Cribriform morphology; Gleason pattern; Grade Group; Prospective study; Prostate cancer

Year:  2020        PMID: 32119879     DOI: 10.1016/j.humpath.2020.02.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.

Authors:  Adrian J Waisman Malaret; Peter Chang; Kehao Zhu; Yingye Zheng; Lisa F Newcomb; Menghan Liu; Jesse K McKenney; James D Brooks; Peter Carroll; Atreya Dash; Christopher P Filson; Martin E Gleave; Michael Liss; Frances M Martin; Todd M Morgan; Peter S Nelson; Daniel W Lin; Andrew A Wagner
Journal:  J Urol       Date:  2021-12-02       Impact factor: 7.450

Review 2.  Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis.

Authors:  Giorgio Ivan Russo; Timo Soeterik; Ignacio Puche-Sanz; Giuseppe Broggi; Arturo Lo Giudice; Cosimo De Nunzio; Riccardo Lombardo; Giancarlo Marra; Giorgio Gandaglia
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-10-10       Impact factor: 5.455

Review 3.  Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.

Authors:  Amanda B Hesterberg; Jennifer B Gordetsky; Paula J Hurley
Journal:  Urology       Date:  2021-05-28       Impact factor: 2.633

4.  Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading.

Authors:  Geert J L H van Leenders; Esther I Verhoef; Eva Hollemans
Journal:  Histopathology       Date:  2020-09-13       Impact factor: 5.087

5.  A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.

Authors:  Amanda B Hesterberg; Brenda L Rios; Elysa M Wolf; Colby Tubbs; Hong Yuen Wong; Kerry R Schaffer; Tamara L Lotan; Giovanna A Giannico; Jennifer B Gordetsky; Paula J Hurley
Journal:  J Pathol Clin Res       Date:  2021-02-18

6.  Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease.

Authors:  Hong Yuen Wong; Quanhu Sheng; Amanda B Hesterberg; Sarah Croessmann; Brenda L Rios; Khem Giri; Jorgen Jackson; Adam X Miranda; Evan Watkins; Kerry R Schaffer; Meredith Donahue; Elizabeth Winkler; David F Penson; Joseph A Smith; S Duke Herrell; Amy N Luckenbaugh; Daniel A Barocas; Young J Kim; Diana Graves; Giovanna A Giannico; Jeffrey C Rathmell; Ben H Park; Jennifer B Gordetsky; Paula J Hurley
Journal:  Nat Commun       Date:  2022-10-13       Impact factor: 17.694

7.  Cribriform pattern does not have a significant impact in Gleason Score ≥7/ISUP Grade ≥2 prostate cancers submitted to radical prostatectomy.

Authors:  Simone Flammia; Marco Frisenda; Martina Maggi; Fabio Massimo Magliocca; Antonio Ciardi; Valeria Panebianco; Ettore De Berardinis; Stefano Salciccia; Giovanni Battista Di Pierro; Alessandro Gentilucci; Francesco Del Giudice; Gian Maria Busetto; Michele Gallucci; Alessandro Sciarra
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.